| Abstract | This is a review and extension of Technology Appraisal Guidance No. 14 issued in October 2000.
NICE has issued guidance to the NHS in England and Wales on the use of pegylated interferons, ribavarin and alfa interferon for the treatment of hepatitis C. Listed below are the key documents for this appraisal; click on the title to link to the relevant document. |